CK
Cummings Keith Lamont
首席财务官
CFOM
内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Cummings Keith Lamont, 首席财务官. Officer active across 1 company, notably Pliant Therapeutics, INC.. Aggregated, 19 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €1.1m. Activity tracked since 3 September 2021. The latest transaction was filed on 20 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Cummings Keith Lamont
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
24,002 股@ US$1.280.035% mcap21.5% 占其流量Common StockSEC:0001746473-26-000012:0
56,650 股0Common StockSEC:0001746473-25-000011:0
20,148 股@ US$11.201116.7% 占其流量Common StockSEC:0001746473-25-000005:0
10,911 股@ US$11.568.9% 占其流量Common StockSEC:0001746473-24-000125:0
21,313 股0Common StockSEC:0001746473-24-000115:0
21,000 股@ US$2.083.1% 占其流量Common StockSEC:0001746473-24-000063:0
55,250 股0Common StockSEC:0001746473-24-000014:0
9,781 股@ US$17.2311.8% 占其流量Common StockSEC:0001746473-24-000005:0
19,771 股@ US$18.009124.1% 占其流量Common StockSEC:0001209191-23-042825:0
38,750 股0Common StockSEC:0001209191-23-042656:0
30,750 股@ US$2.084.5% 占其流量Common StockSEC:0001209191-23-037143:0
5,800 股@ US$2.080.9% 占其流量Common StockSEC:0001209191-23-036465:0
9,960 股@ US$26.520918.4% 占其流量Common StockSEC:0001209191-23-022364:0
19,375 股0Common StockSEC:0001209191-23-021917:0
54,000 股0Common StockSEC:0001140361-23-003181:0
12,500 股@ US$2.081.8% 占其流量Common StockSEC:0001140361-23-002783:0
4,000 股@ US$2.080.6% 占其流量Common StockSEC:0001140361-22-047041:0
19,375 股0Common StockSEC:0001140361-22-046571:0
20,000 股@ US$2.082.8% 占其流量Common StockSEC:0001209191-21-054876:0
About Cummings Keith Lamont
Keith Lamont Cummings is the Chief Financial Officer at Pliant Therapeutics, Inc. He oversees the financial operations of the company, ensuring compliance and efficiency in financial processes. His expertise is essential for Pliant's financial management.